1 hr ago | China Daily
Chinese pharma companies look West
Zhejiang Hisun Pharmaceutical Co's pavilion at a fair in Beijing. By setting up a joint venture with US-based Pfizer Inc in September, Hisun made a breakthrough in China's pharmaceutical industry by taking a controlling stake in the JV with Pfizer, the world's largest drug-maker by sales.
1 Great Dividend You Can Buy Right Now
Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.
Why MannKind's Afrezza Will Succeed Where Pfizer Failed
According to the American Diabetes Association, over 25 million people in the US alone have diabetes and the numbers keep on growing.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK) News: Expectations Of...
Editor's Note: Pfizer Inc. , Merck & Co., Inc. , Petroleo Brasileiro Petrobras SA , American Express Company Feds offer more benefits to 390 laid-off Pfizer workers Nearly 400 former workers at Pfizer Inc.
Pfizer bypasses pharmacies, begins selling Viagra online directly to men
Concerned about continued profit losses from competitors and online counterfeiters, drug giant Pfizer Inc.
Pfizer Inc. to Close Little Island Plant - 136 Jobs Lost
Hey, Pfizer's hiring! The jobs of more than 130 people are under threat at a manufacturing plant operated by pharmaceutical company Pfizer in Co Cork.
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the Health Care Select Sector SPDR Fund , which shed 22.3 million shares, or a 13.4% decrease week over week.
Dementia research: A 66m extra funding pledged to tackle 'shockingly low' dementia rates
Pledging to increase research funding to A 66million, the PM said he wants detection rates to hit 60% by 2016 from 37% now Speaking on his US visit Mr Cameron said: "Dementia is a devastating disease - not just for sufferers but for families and friends too.
Athersys Reports First Quarter 2013 Results
CLEVELAND, May 14, 2013 -- Athersys, Inc. today announced its financial results for the three months ended March 31, 2013.
Optimer Pharmaceuticals, Inc. Appoints as Chief Operating Officer
Eric Sirota as Chief Operating Officer. Mr. Sirota will be responsible for directing Optimer's corporate strategy with regard to DIFICIDA .
Pfizer Inc. Lays Off 25 After Levoxyl Recall
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Pfizer recently released about a fifth of its remaining local workforce, following a second recall of the drug Levoxyl.
Teva: An Ideal Long-Term Pharma Stock
A study released by the IMS Institute for Health Informatics finds that per capita spending on medicines declined by $33 in 2012.
Baby Boomers Are Money-Making Machines For Big Pharma
Several pharmaceutical companies are working on or have developed key drugs to treat diabetes.
Stocks Finish Mixed as Fed Rumors Trump Retail Sales
"Markets can't go up every day -- unless that day is Tuesday, of course," quipped Schaeffer's Senior Technical Strategist Ryan Detrick, CMT.
U.S. STOCKS-Wall St ends near flat after recent highs; healthcare climbs
U.S. stocks closed little changed on Monday, pausing after hitting record highs last week, but strength in healthcare issues helped to keep declines in check.
Pfizer Inc. Announces 11 Abstracts for Tofacitinib to be Presented at the 2013 Annual Meeting
Pfizer Inc. Announces 11 Abstracts for Tofacitinib to be Presented at the European League Against Rheumatism 2013 Annual Meeting Staying up-to-date has never been simpler.
Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:- Pain Therapeutics, Inc.
Free Research Reports on PTIE, TSL, AL and GVA Issued by the Bedford Report
The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
The company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.
Pain Therapeutics Inc. dipped 45.01% to $5.32 in the pre-market session after the company CEO revealed a letter from Pfizer of reassessing its endorsement of the Remoxy program.